These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 37376824)

  • 1. How reliable is restaging MRI after neoadjuvant therapy in rectal cancer?
    Gefen R; Garoufalia Z; Horesh N; Freund MR; Emile SH; Parlade A; Berho M; Allende D; DaSilva G; Wexner SD
    Colorectal Dis; 2023 Aug; 25(8):1631-1637. PubMed ID: 37376824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of preoperative magnetic resonance imaging with postoperative pathology results in rectal cancer patients undergoing neoadjuvant therapy.
    Akgül Ö; Martlı HF; Göktaş A; Pak MA; Tez M
    ANZ J Surg; 2024 Jun; 94(6):1133-1137. PubMed ID: 38345184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging for assessment of rectal cancer nodes after chemoradiotherapy: A single center experience.
    Barbaro B; Carafa MRP; Minordi LM; Testa P; Tatulli G; Carano D; Fiorillo C; Chiloiro G; Romano A; Valentini V; Gambacorta MA
    Radiother Oncol; 2024 Apr; 193():110124. PubMed ID: 38309586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy.
    Çelik H; Barlık F; Sökmen S; Terzi C; Canda AE; Sağol Ö; Sarıoğlu S; Ünlü M; Bilkay Görken İ; Arıcan Alıcıkuş Z; Öztop İ
    Diagn Interv Radiol; 2023 Mar; 29(2):219-227. PubMed ID: 36971272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucinous Degeneration on MRI After Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: Frequency and Association With Clinical Outcomes.
    Miranda J; Pinto PVA; Kinochita F; Garcia CM; El Homsi M; Vilela de Oliveira C; Pandini RV; Nahas CSR; Nahas SC; Gollub MJ; Horvat N
    AJR Am J Roentgenol; 2023 Aug; 221(2):206-216. PubMed ID: 36919880
    [No Abstract]   [Full Text] [Related]  

  • 6. FDG-PET/MRI for Nonoperative Management of Rectal Cancer: A Prospective Pilot Study.
    Ince S; Itani M; Henke LE; Smith RK; Wise PE; Mutch MG; Glasgow SC; Silviera ML; Pedersen KS; Hunt SR; Kim H; Fraum TJ
    Tomography; 2022 Nov; 8(6):2723-2734. PubMed ID: 36412686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI assessment of rectal cancer response to neoadjuvant therapy: a multireader study.
    Yuval JB; Patil S; Gangai N; Omer DM; Akselrod DG; Fung A; Harmath CB; Kampalath R; Krehbiel K; Lee S; Liu PS; Millet JD; O'Malley RB; Purysko AS; Veniero JC; Wasnik AP; Garcia-Aguilar J; Gollub MJ
    Eur Radiol; 2023 Aug; 33(8):5761-5768. PubMed ID: 36814032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Split scar sign to predict complete response in rectal cancer after neoadjuvant chemoradiotherapy: systematic review and meta-analysis.
    Torri GB; Wiethan CP; Langer FW; de Oliveira GS; Meirelles AVB; Horvat N; Tse JR; Dias AB; Altmayer S
    Eur Radiol; 2024 Jun; 34(6):3874-3881. PubMed ID: 37979009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sense and nonsense of yT-staging on MRI after chemoradiotherapy in rectal cancer.
    El Khababi N; Beets-Tan RGH; Tissier R; Lahaye MJ; Maas M; Curvo-Semedo L; Dresen RC; Nougaret S; Beets GL; Lambregts DMJ;
    Colorectal Dis; 2023 Sep; 25(9):1878-1887. PubMed ID: 37545140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restaging of locally advanced rectal cancer with magnetic resonance imaging and endoluminal ultrasound after preoperative chemoradiotherapy: a systemic review and meta-analysis.
    Zhao RS; Wang H; Zhou ZY; Zhou Q; Mulholland MW
    Dis Colon Rectum; 2014 Mar; 57(3):388-95. PubMed ID: 24509465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Watch & wait - Post neoadjuvant imaging for rectal cancer.
    El Homsi M; Bercz A; Chahwan S; Fernandes MC; Javed-Tayyab S; Golia Pernicka JS; Nincevic J; Paroder V; Ruby L; Smith JJ; Petkovska I
    Clin Imaging; 2024 Jun; 110():110166. PubMed ID: 38669916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative MRI accuracy after neoadjuvant chemoradiation for locally advanced rectal cancer.
    Popiţa AR; Rusu A; Muntean V; Cadariu PA; Irimie A; Lisencu C; Pop B; Resiga L; Fekete Z; Badea R
    Med Pharm Rep; 2023 Jul; 96(3):258-268. PubMed ID: 37577010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restaging MRI of Rectal Adenocarcinoma after Neoadjuvant Chemoradiotherapy: Imaging Findings and Potential Pitfalls.
    Awiwi MO; Kaur H; Ernst R; Rauch GM; Morani AC; Stanietzky N; Palmquist SM; Salem UI
    Radiographics; 2023 Apr; 43(4):e220135. PubMed ID: 36927125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Positive Radial Margin on Restaging MRI of Patients with Low Rectal Cancer: Can We Do Better?
    Patra A; Lakhani A; Augustine A; Mohapatra P; Eapen A; Singh A; Masih D; Ram TS; Jesudason MR; Mittal R; Chandramohan A
    Indian J Radiol Imaging; 2024 Jan; 34(1):85-94. PubMed ID: 38106864
    [No Abstract]   [Full Text] [Related]  

  • 15. Is It Really Gone? Assessing Response to Neoadjuvant Therapy in Rectal Cancer.
    Kimura C; Crowder SE; Kin C
    J Gastrointest Cancer; 2023 Sep; 54(3):703-711. PubMed ID: 36417142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limits of Clinical Restaging in Detecting Responders After Neoadjuvant Therapies for Rectal Cancer.
    Deidda S; Spolverato G; Capelli G; Bao RQ; Bettoni L; Crimì F; Zorcolo L; Pucciarelli S; Restivo A
    Dis Colon Rectum; 2023 Jul; 66(7):957-964. PubMed ID: 36538694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison.
    Zhang Z; Chen Y; Wen Z; Wu X; Que Y; Ma Y; Wu Y; Liu Q; Fan W; Yu S
    Cancer Imaging; 2023 Jul; 23(1):67. PubMed ID: 37443085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
    Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
    Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postchemoradiation magnetic resonance imaging circumferential resection margin predicts treatment failure after multidisciplinary directed sphincter preservation in low rectal cancer.
    Kim SJ; Lee YJ; Park MY; Yang SY; Han YD; Cho MS; Hur H; Lee KY; Lim JS; Min BS
    J Surg Oncol; 2023 Dec; 128(8):1365-1371. PubMed ID: 37732720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging accuracy in staging early and locally advanced rectal cancer.
    Arndt K; Vigna C; Kaul S; Fabrizio A; Cataldo T; Smith M; Messaris E
    Surg Oncol; 2023 Oct; 50():101987. PubMed ID: 37717374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.